6
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Subcutaneous Interleukin-2 in Combination with Anti-retroviral Therapy for Treatment of HIV-1-Infected Subjects

Pages 153-160 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

E. Florence, E. Bottieau, L. Lynen & R. Colebunders. (2002) PATIENTS WITH HIV INFECTION AND FEVER: A DIAGNOSTIC APPROACH. Acta Clinica Belgica 57:4, pages 184-190.
Read now

Articles from other publishers (12)

John M Wrangle, Vamsidhar Velcheti, Manish R Patel, Elizabeth Garrett-Mayer, Elizabeth G Hill, James G Ravenel, Jeffrey S Miller, Mohammad Farhad, Kate Anderton, Kathryn Lindsey, Michele Taffaro-Neskey, Carol Sherman, Samantha Suriano, Marzena Swiderska-Syn, Amy Sion, Joni Harris, Andie R Edwards, Julie A Rytlewski, Catherine M Sanders, Erik C Yusko, Mark D Robinson, Carsten Krieg, William L Redmond, Jack O Egan, Peter R Rhode, Emily K Jeng, Amy D Rock, Hing C Wong & Mark P Rubinstein. (2018) ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. The Lancet Oncology 19:5, pages 694-704.
Crossref
Lishomwa C. Ndhlovu, Elizabeth Sinclair, Lorrie Epling, Qi Xuan Tan, Terence Ho, Aashish R. Jha, Ijeoma Eccles-James, Camilla Tincati, Jay A. Levy, Douglas F. Nixon, Frederick M. Hecht & Jason D. Barbour. (2010) IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (TH17) Cells in the Periphery. Journal of Clinical Immunology 30:5, pages 681-692.
Crossref
Jorge A. Tavel. (2010) Effects of Intermittent IL-2 Alone or with Peri-Cycle Antiretroviral Therapy in Early HIV Infection: The STALWART Study. PLoS ONE 5:2, pages e9334.
Crossref
Martin R GoodierAdam Coleman. (2009) Innate natural killer cell phenotype and function during HIV-1 infection: potential avenues for modulation. HIV Therapy 3:2, pages 161-170.
Crossref
Jakob Michaëlsson, Brian R. Long, Christopher P. Loo, Lewis L. Lanier, Gerald Spotts, Frederick M. Hecht & Douglas F. Nixon. (2008) Immune Reconstitution of CD56 dim NK Cells in Individuals with Primary HIV‐1 Infection Treated with Interleukin‐2 . The Journal of Infectious Diseases 197:1, pages 117-125.
Crossref
Janos Nacsa, Yvette Edghill-Smith, Wen-Po Tsai, David Venzon, Elzbieta Tryniszewska, Anna Hryniewicz, Marcin Moniuszko, Audrey Kinter, Kendall A. Smith & Genoveffa Franchini. (2005) Contrasting Effects of Low-Dose IL-2 on Vaccine-Boosted Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cells in Macaques Chronically Infected with SIVmac251. The Journal of Immunology 174:4, pages 1913-1921.
Crossref
Massimo Alfano & Guido Poli. (2005) Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Molecular Immunology 42:2, pages 161-182.
Crossref
Genoveffa Franchini. (2003) Modeling immune intervention strategies for HIV-1 infection of humans in the macaque model. Clinical and Applied Immunology Reviews 3:6, pages 289-306.
Crossref
Genoveffa Franchini, Janos Nacsa, Zdenek Hel & Elzbieta Tryniszewska. (2002) Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model. Vaccine 20, pages A52-A60.
Crossref
Carla C. Romano, Maria J.S. Mendes-Giannini, Alberto J.S. Duarte & Gil Benard. (2002) IL-12 AND NEUTRALIZATION OF ENDOGENOUS IL-10 REVERT THE IN VITRO ANTIGEN-SPECIFIC CELLULAR IMMUNOSUPPRESSION OF PARACOCCIDIOIDOMYCOSIS PATIENTS. Cytokine 18:3, pages 149-157.
Crossref
Sarah L Pett & Sean Emery. (2001) Immunomodulators as adjunctive therapy for HIV-1 infection. Journal of Clinical Virology 22:3, pages 289-295.
Crossref
Irini Sereti, Betsey Herpin, Julia A. Metcalf, Randy Stevens, Michael W. Baseler, Claire W. Hallahan, Joseph A. Kovacs, Richard T. Davey & H. Clifford Lane. (2001) CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients. AIDS 15:14, pages 1765-1775.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.